Back to company

ELDON BIOLOGICALS A/S: Financial statements 2019

CVR: 26747007

ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 9,536,982 and a net result of DKK 3,309,735 compared with DKK 3,754,766 the year before. That is an increase of 0.2% compared with the year before. Equity amounted to DKK 10,451,740. The solvency ratio was 68.6%. The company had 6 employees in the financial year.

Gross Profit
9,536,982 kr.
Profit/Loss
3,309,735 kr.
Equity
10,451,740 kr.
Total Assets
15,245,111 kr.
Employees
6

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-9.5 mio.3.3 mio.10.5 mio.6
2018-9.5 mio.3.8 mio.7.1 mio.7
2017-8 mio.2.6 mio.3.9 mio.7
2016-6.1 mio.1.2 mio.1.3 mio.-
2015-6.1 mio.1.5 mio.319 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

ELDON BIOLOGICALS A/S appoints new auditorMay 1, 2019

As of May 1, 2019, REVISION SJÆLLAND GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of ELDON BIOLOGICALS A/S.

Auditor steps down at ELDON BIOLOGICALS A/SMay 1, 2019

As of May 1, 2019, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of ELDON BIOLOGICALS A/S.

ELDON BIOLOGICALS A/S: The 2018 annual report is outJan 2, 2019

ELDON BIOLOGICALS A/S has published its annual report for 2018. Gross profit came to DKK 9,520,051, and the net result was DKK 3,754,766.

About ELDON BIOLOGICALS A/S

ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees. In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity amounted to DKK 42,055,949.